Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001555667-14-000069
Filing Date
2014-08-01
Accepted
2014-08-01 16:50:15
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q szym-2014x06x30x10xq.htm 10-Q 1270744
2 EX-31.1 szym2014-06x30exx311.htm EX-31.1 12632
3 EX-31.2 szym2014-06x30exx312.htm EX-31.2 12782
4 EX-32.1 szym2014-06x30exx321.htm EX-32.1 8472
  Complete submission text file 0001555667-14-000069.txt   8990546

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT szym-20140630.xml EX-101.INS 1325712
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT szym-20140630.xsd EX-101.SCH 54176
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT szym-20140630_cal.xml EX-101.CAL 85359
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT szym-20140630_def.xml EX-101.DEF 302099
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT szym-20140630_lab.xml EX-101.LAB 711559
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT szym-20140630_pre.xml EX-101.PRE 441444
Mailing Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080
Business Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080 650-780-4777
SOLAZYME INC (Filer) CIK: 0001311230 (see all company filings)

EIN.: 331077078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35189 | Film No.: 141010649
SIC: 2860 Industrial Organic Chemicals